Effects of pharmaceuticals present in aquatic environment on Phase I metabolism in fish

Environmental Toxicology and Pharmacology

Volumn 40, Issue 2, 2015, Pages 430-444

  Burkina, Viktoriia ^a   Zlabek, Vladimir ^a   Zamaratskaia, Galia ^a,b  

^a UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Aquatic invertebrates; Cytochromes P450; Drugs; Nuclear receptor

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; AROMATASE; CELL NUCLEUS RECEPTOR; CLOFIBRIC ACID; CLOTRIMAZOLE; CYTOCHROME P450; CYTOCHROME P450 17; CYTOCHROME P450 1A1; CYTOCHROME P450 3A; DEXAMETHASONE; DRUG; ESTROGEN; FIBRIC ACID DERIVATIVE; FLUOXETINE; GEMFIBROZIL; GESTAGEN; KETOCONAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; PAROXETINE; PYRROLE; SEROTONIN UPTAKE INHIBITOR; STEROID HORMONE; UNINDEXED DRUG; VERAPAMIL; XENOBIOTIC AGENT; FISH PROTEIN; WATER POLLUTANT;

AQUATIC ENVIRONMENT; CATALYSIS; DETOXIFICATION; DRUG METABOLISM; ECOTOXICOLOGY; ENVIRONMENTAL IMPACT; ENZYME ACTIVITY; FISH; GENE EXPRESSION; HORMONE METABOLISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; ANALYSIS; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; LIVER; METABOLISM; TOXICITY; WATER POLLUTANT;

INVERTEBRATA; MAMMALIA;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FISH PROTEINS; FISHES; LIVER; PHARMACEUTICAL PREPARATIONS; WATER POLLUTANTS, CHEMICAL;

EID: 84939451152     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.07.016     Document Type: Review

References (207)

1. Abdel-Hafez G., Lahnsteiner F., Mansour N. Possibilities to control Ichthyophthirius multifiliis infestation with medicated feed in rainbow trout (Oncorhynchus mykiss) and chub (Leuciscus cephalus). Parasitol. Res. 2014, 1119-1126.
2. Abnet C.C., Tanguay R.L., Hahn M.E., Heideman W., Peterson R.E. Two forms of aryl hydrocarbon receptor type 2 in rainbow trout (Oncorhynchus mykiss): evidence for differential expression and enhancer specificity. J. Biol. Chem. 1999, 274:15159-15166.
3. Abreu M.S.d., Koakoski G., Ferreira D., Oliveira T.A., Rosa J.G.S.d., Gusso D., Giacomini A.C.V., Piato A.L., Barcellos L.J.G. Diazepam and fluoxetine decrease the stress response in zebrafish. PLoS ONE 2014, 9:e103232.
4. Adlercreutz H., Fotsis T., Bannwart C., Hämäläinen E., Bloigu S., Ollus A. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J. Steroid Biochem. 1986, 24:289-296.
5. Airhart M.J., Lee D.H., Wilson T.D., Miller B.E., Miller M.N., Skalko R.G. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol. Teratol. 2007, 29:652-664.
6. Al-Odaini N.A., Zakaria M.P., Yaziz M.I., Surif S., Abdulghani M. The occurrence of human pharmaceuticals in wastewater effluents and surface water of Langat River and its tributaries, Malaysia. Int. J. Environ. Anal. Chem. 2013, 93:245-264.
7. Al-Rifai J.H., Gabelish C.L., Schäfer A.I. Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. Chemosphere 2007, 69:803-815.
8. Anderson M.J., Olsen H., Matsumura F., Hinton D.E. In vivo modulation of 17β-estradiol-induced vitellogenin synthesis and estrogen receptor in rainbow trout (Oncorhynchus mykiss) liver cells by β-naphthoflavone. Toxicol. Appl. Pharmacol. 1996, 137:210-218.
9. Andreasen E.A., Hahn M.E., Heideman W., Peterson R.E., Tanguay R.L. The zebrafish (Danio rerio) aryl hydrocarbon receptor type 1 is a novel vertebrate receptor. Mol. Pharmacol. 2002, 62:234-249.
10. Ankley G.T., Jensen K.M., Durhan E.J., Makynen E.A., Butterworth B.C., Kahl M.D., Villeneuve D.L., Linnum A., Gray L.E., Cardon M., Wilson V.S. Effects of two fungicides with multiple modes of action on reproductive endocrine function in the fathead minnow (Pimephales promelas). Toxicol. Sci. 2005, 86:300-308.
11. Ankley G.T., Kahl M.D., Jensen K.M., Hornung M.W., Korte J.J., Makynen E.A., Leino R.L. Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol. Sci. 2002, 67:121-130.
12. Aris A.Z., Shamsuddin A.S., Praveena S.M. Occurrence of 17α-ethynylestradiol (EE2) in the environment and effect on exposed biota: a review. Environ. Int. 2014, 69:104-119.
13. Arukwe A., Goksøyr A. Changes in three hepatic cytochrome P450 subfamilies during a reproductive cycle in turbot (Scophthalmus maximus L.). J. Exp. Zool. 1997, 277:313-325.
14. Ascar L., Ahumada I., Lopez A., Quintanilla F., Leiva K. Nonsteroidal anti-inflammatory drug determination in water samples by HPLC-DAD under isocratic conditions. J. Brazil. Chem. Soc. 2013, 24:1160-1166.
15. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333:167-184.
16. Ayub M., Levell M.J. Inhibition of testicular 17α-hydroxylase and 17,20-lyase but not 3β-hydroxysteroid dehydrogenase-isomerase or 17β-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs. J. Steroid Biochem. 1987, 28:521-531.
17. Bartram A.E., Winter M.J., Huggett D.B., McCormack P., Constantine L.A., Hetheridge M.J., Hutchinson T.H., Kinter L.B., Ericson J.F., Sumpter J.P., Owen S.F. In vivo and in vitro liver and gill EROD activity in rainbow trout (Oncorhynchus mykiss) exposed to the beta-blocker propranolol. Environ. Toxicol. 2012, 27:573-582.
18. Batt A.L., Kostich M.S., Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal. Chem. 2008, 80:5021-5030.
19. Baudiffier D., Hinfray N., Ravaud C., Creusot N., Chadili E., Porcher J.-M., Schulz R.W., Brion F. Effect of in vivo chronic exposure to clotrimazole on zebrafish testis function. Environ. Sci. Pollut. Res. 2013, 20:2747-2760.
20. Baudiffier D., Hinfray N., Vosges M., Creusot N., Chadili E., Porcher J.-M., Schulz R.W., Brion F. A critical role of follicle-stimulating hormone (Fsh) in mediating the effect of clotrimazole on testicular steroidogenesis in adult zebrafish. Toxicology 2012, 298:30-39.
21. Beijer K., Abrahamson A., Brunström B., Brandt I. CYP1A inhibition in fish gill filaments: a novel assay applied on pharmaceuticals and other chemicals. Aquat. Toxicol. 2010, 96:145-150.
22. Bemanian V., Male R., Goksoyr A. The aryl hydrocarbon receptor-mediated disruption of vitellogenin synthesis in the fish liver: cross-talk between AHR- and ERalpha-signalling pathways. Comp. Hepatol. 2004, 3:2.
23. Besse J.-P., Latour J.-F., Garric J. Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?. Environ. Int. 2012, 39:73-86.
24. Bhandari R.K., Deem S.L., Holliday D.K., Jandegian C.M., Kassotis C.D., Nagel S.C., Tillitt D.E., vom Saal F.S., Rosenfeld C.S. Effects of the environmental estrogenic contaminants bisphenol A and 17α-ethinyl estradiol on sexual development and adult behaviors in aquatic wildlife species. Gen. Comp. Endocrinol. 2015, 214:195-219.
25. Bisesi J.H., Bridges W., Klaine S.J. Effects of the antidepressant venlafaxine on fish brain serotonin and predation behavior. Aquat. Toxicol. 2014, 148:130-138.
26. Blair B.D., Crago J.P., Hedman C.J., Klaper R.D. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 2013, 93:2116-2123.
27. Bradshaw T.D., Trapani V., Vasselin D.A., Westwell A.D. The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?. Curr. Pharm. Design 2002, 8:2475-2490.
28. Braga O., Smythe G.A., Schafer A.I., Feitz A.J. Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environ. Sci. Technol. 2005, 39:3351-3358.
29. Bresolin T., de Freitas Rebelo M., Celso Dias Bainy A. Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2005, 140:403-407.
30. Brodin T., Fick J., Jonsson M., Klaminder J. Dilute concentrations of a psychiatric drug alter behavior of fish from natural populations. Science 2013, 339:814-815.
31. Brown K.D., Kulis J., Thomson B., Chapman T.H., Mawhinney D.B. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 2006, 366:772-783.
32. Brozinski J.-M., Lahti M., Oikari A., Kronberg L. Detection of naproxen and its metabolites in fish bile following intraperitoneal and aqueous exposure. Environ. Sci. Pollut. Res. 2011, 18:811-818.
33. Burkina V., Zamaratskaia G., Randak T., Li Z.H., Fedorova G., Pickova J., Zlabek V. Verapamil does not modify catalytic activity of CYP450 in rainbow trout after long-term exposure. Ecotoxicol. Environ. Saf. 2012, 79:148-152.
34. Burkina V., Zlabek V., Zamaratskaia G. Clotrimazole, but not dexamethasone, is a potent in vitro inhibitor of cytochrome P450 isoforms CYP1A and CYP3A in rainbow trout. Chemosphere 2013, 92:1099-1104.
35. Cajaraville M.P., Cancio I., Ibabe A., Orbea A. Peroxisome proliferation as a biomarker in environmental pollution assessment. Microsc. Res. Tech. 2003, 61:191-202.
36. Carney S.A., Chen J., Burns C.G., Xiong K.M., Peterson R.E., Heideman W. Aryl hydrocarbon receptor activation produces heart-specific transcriptional and toxic responses in developing zebrafish. Mol. Pharmacol. 2006, 70:549-561.
37. Celander M., Bremer J., Hahn M.E., Stegeman J.J. Glucocorticoid-xenobiotic interactions: dexamethasone-mediated potentiation of cytochrome P4501A induction by β-naphthoflavone in a fish hepatoma cell line (PLHC-1). Environ. Toxicol. Chem. 1997, 16:900-907.
38. Celander M., Ronis M., Förlin L. Initial characterization of a constitutive cytochrome P-450 isoenzyme in rainbow trout liver. Mar. Environ. Res. 1989, 28:9-13.
39. Chang H., Hu J.Y., Shao B. Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters. Environ. Sci. Technol. 2007, 41:3462-3468.
40. Cheshenko K., Brion F., Le Page Y., Hinfray N., Pakdel F., Kah O., Segner H., Eggen R. Expression of zebra fish aromatase cyp19a and cyp19b genes in response to the ligands of estrogen receptor and aryl hydrocarbon receptor. Toxicol. Sci. 2007, 96:255-267.
41. Christen V., Fent K. Tissue-, sex- and development-specific transcription profiles of eight UDP-glucuronosyltransferase genes in zebrafish (Danio rerio) and their regulation by activator of aryl hydrocarbon receptor. Aquat. Toxicol. 2014, 150:93-102.
42. Cizkova K., Konieczna A., Erdosova B., Lichnovska R., Ehrmann J. Peroxisome proliferator-activated receptors in regulation of cytochromes P450: new way to overcome multidrug resistance?. J. Biomed. Biotechnol. 2012, 2012:10.
43. Clements S., Schreck C.B. Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha). Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2007, 147:43-49.
44. Collado N., Rodriguez-Mozaz S., Gros M., Rubirola A., Barceló D., Comas J., Rodriguez-Roda I., Buttiglieri G. Pharmaceuticals occurrence in a WWTP with significant industrial contribution and its input into the river system. Environ. Pollut. 2014, 185:202-212.
45. Combalbert S., Hernandez-Raquet G. Occurrence, fate, and biodegradation of estrogens in sewage and manure. Appl. Microbiol. Biotechnol. 2010, 86:1671-1692.
46. Corcoran J., Lange A., Cumming R.I., Owen S.F., Ball J.S., Tyler C.R., Winter M.J. Bioavailability of the imidazole antifungal agent clotrimazole and its effects on key biotransformation genes in the common carp (Cyprinus carpio). Aquat. Toxicol. 2014, 152:57-65.
47. Crago J., Klaper R.D. Influence of gender, feeding regimen, and exposure duration on gene expression associated with xenobiotic metabolism in fathead minnows (Pimephales promelas). Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2011, 154:208-212.
48. Cuklev F., Kristiansson E., Fick J., Asker N., Forlin L., Larsson D.G.J. Diclofenac in fish: blood plasma levels similar to human therapeutic levels affect global hepatic gene expression. Environ. Toxicol. Chem. 2011, 30:2126-2134.
49. Dang Z. Fish biomarkers for regulatory identification of endocrine disrupting chemicals. Environ. Pollut. 2014, 185:266-270.
50. Di Poi C., Darmaillacq A.-S., Dickel L., Boulouard M., Bellanger C. Effects of perinatal exposure to waterborne fluoxetine on memory processing in the cuttlefish Sepia officinalis. Aquat. Toxicol. 2013, 132-133:84-91.
51. Dineshkumar B., Raghuram T., Radhaiah G., Krishnaswamy K. Profile of drug use in urban and rural India. Pharmacoeconomics 1995, 7:332-346.
52. Domingues I., Oliveira R., Musso C., Cardoso M., Soares A.M., Loureiro S. Prochloraz effects on biomarkers activity in zebrafish early life stages and adults. Environ. Toxicol. 2013, 28:155-163.
53. Du Z.-Y., Clouet P., Degrace P., Zheng W.-H., Froyland L., Tian L.-X., Liu Y.-J. Hypolipidaemic effects of fenofibrate and fasting in the herbivorous grass carp (Ctenopharyngodon idella) fed a high-fat diet. Br. J. Nutr. 2008, 100:1200-1212.
54. Dvorak Z. Drug-drug interactions by azole antifungals: beyond a dogma of CYP3A4 enzyme activity inhibition. Toxicol. Lett. 2011, 202:129-132.
55. Eide M., Karlsen O.A., Kryvi H., Olsvik P.A., Goksøyr A. Precision-cut liver slices of Atlantic cod (Gadus morhua): an in vitro system for studying the effects of environmental contaminants. Aquat. Toxicol. 2014, 153:110-115.
56. El-Alfy A., Schlenk D. Potential mechanisms of the enhancement of aldicarb toxicity to Japanese medaka, Oryzias latipes, at high salinity. Toxicol. Appl. Pharmacol. 1998, 152:175-183.
57. Elia A.C., Ciccotelli V., Pacini N., Doerr A.J.M., Gili M., Natali M., Gasco L., Prearo M., Abete M.C. Transferability of oxytetracycline (OTC) from feed to carp muscle and evaluation of the antibiotic effects on antioxidant systems in liver and kidney. Fish Physiol. Biochem. 2014, 40:1055-1068.
58. Elskus A.A. Estradiol and estriol suppress CYP1A expression in rainbow trout primary hepatocytes. Mar. Environ. Res. 2004, 58:463-467.
59. Emblidge J.P., DeLorenzo M.E. Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environ. Res. 2006, 100:216-226.
60. ESAC-Net,. http://www.ecdc.europa.eu/en/activities/surveillance/ESAC-Net/Pages/index.aspx.
61. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45:75-92.
62. Fernandes D., Bebianno M.J., Porte C. Mitochondrial metabolism of 17α-hydroxyprogesterone in male sea bass (Dicentrarchus labrax): a potential target for endocrine disruptors. Aquat. Toxicol. 2007, 85:258-266.
63. Fernandes D., Pujol S., Aceña J., Perez S., Barceló D., Porte C. The in vitro interference of synthetic progestogens with carp steroidogenic enzymes. Aquat. Toxicol. 2014, 155:314-321.
64. Fernandes D., Schnell S., Porte C. Can pharmaceuticals interfere with the synthesis of active androgens in male fish? An in vitro study. Mar. Pollut. Bull. 2011, 62:2250-2253.
65. Frédéric O., Yves P. Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent. Chemosphere 2014, 115:31-39.
66. Gao L., Shi Y., Li W., Niu H., Liu J., Cai Y. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China. Chemosphere 2012, 86:665-671.
67. Gaworecki K.M., Klaine S.J. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat. Toxicol. 2008, 88:207-213.
68. Giuliani M.E., Regoli F. Identification of the Nrf2-Keap1 pathway in the European eel Anguilla anguilla: role for a transcriptional regulation of antioxidant genes in aquatic organisms. Aquat. Toxicol. 2014, 150:117-123.
69. Goldstone J., McArthur A., Kubota A., Zanette J., Parente T., Jonsson M., Nelson D., Stegeman J. Identification and developmental expression of the full complement of cytochrome P450 genes in zebrafish. BMC Genomics 2010, 11:643.
70. Golovko O., Kumar V., Fedorova G., Randak T., Grabic R. Removal and seasonal variability of selected analgesics/anti-inflammatory, anti-hypertensive/cardiovascular pharmaceuticals and UV filters in wastewater treatment plant. Environ. Sci. Pollut. Res. 2014, 1-8.
71. Gomez C.F., Constantine L., Moen M., Vaz A., Wang W., Huggett D.B. Ibuprofen metabolism in the liver and gill of rainbow trout, Oncorhynchus mykiss. Bull. Environ. Contam. Toxicol. 2011, 86:247-251.
72. Gonzalez J.F., Reimschuessel R., Shaikh B., Kane A.S. Kinetics of hepatic phase I and II biotransformation reactions in eight finfish species. Mar. Environ. Res. 2009, 67:183-188.
73. Grabicova K., Grabic R., Blaha M., Kumar V., Cerveny D., Fedorova G., Randak T. Presence of pharmaceuticals in benthic fauna living in a small stream affected by effluent from a municipal sewage treatment plant. Water Res. 2015, 145-153. 10.1016/j.watres.2014.09.018.
74. Gräns J., Wassmur B., Celander M.C. One-way inhibiting cross-talk between arylhydrocarbon receptor (AhR) and estrogen receptor (ER) signaling in primary cultures of rainbow trout hepatocytes. Aquat. Toxicol. 2010, 100:263-270.
75. Gray E.S., Woodin B.R., Stegeman J.J. Sex differences in hepatic monooxygenases in winter flounder (Pseudopleuronectes americanus) and scup (Stenotomus chrysops) and regulation of P450 forms by estradiol. J. Exp. Zool. 1991, 259:330-342.
76. Guardiola F.A., Cerezuela R., Meseguer J., Esteban M.A. Modulation of the immune parameters and expression of genes of gilthead seabream (Sparus aurata L.) by dietary administration of oxytetracycline. Aquaculture 2012, 334-337:51-57.
77. Hahn M.E. Aryl hydrocarbon receptors: diversity and evolution. Chem. Biol. Interact. 2002, 141:131-160.
78. Hahn M.E., Karchner S.I., Evans B.R., Franks D.G., Merson R.R., Lapseritis J.M. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J. Exp. Zool. Part A 2006, 305A:693-706.
79. Hailong Z., Huifeng W., Chunyang L., Xiaoping D., Jiping Z., Linlin C., Qinzhao X. Toxicology mechanism of the persistent organic pollutants (POPs) in fish through AhR pathway. Toxicol. Mech. Methods 2010, 20:279-286.
80. Hansson M.C., Wittzell H., Persson K., von Schantz T. Characterization of two distinct aryl hydrocarbon receptor (AhR2) genes in Atlantic salmon (Salmo salar) and evidence for multiple AhR2 gene lineages in salmonid fish. Gene 2003, 303:197-206.
81. Hasselberg L., Grosvik B.E., Goksoyr A., Celander M.C. Interactions between xenoestrogens and ketoconazole on hepatic CYP1A and CYP3A, in juvenile Atlantic cod (Gadus morhua). Comp. Hepatol. 2005, 4:2.
82. Hedgespeth M.L., Nilsson P.A., Berglund O. Ecological implications of altered fish foraging after exposure to an antidepressant pharmaceutical. Aquat. Toxicol. 2014.
83. Hegelund T., Ottosson K., Radinger M., Tomberg P., Celander M.C. Effects of the antifungal imidazole ketoconazole on CYPIA and CYP3A in rainbow trout and killifish. Environ. Toxicol. Chem. 2004, 23:1326-1334.
84. Hemeryck A., Belpaire F.M. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr. Drug Metab. 2002, 3:13-37.
85. Hersh E.V., Moore P.A. Drug interactions in dentistry: the importance of knowing your CYPs. J. Am. Dent. Assoc. 2004, 135:298-311.
86. Hinfray N., Baudiffier D., Leal M.C., Porcher J.-M., Aït-Aïssa S., Le Gac F., Schulz R.W., Brion F. Characterization of testicular expression of P450 17α-hydroxylase, 17,20-lyase in zebrafish and its perturbation by the pharmaceutical fungicide clotrimazole. Gen. Comp. Endocrinol. 2011, 174:309-317.
87. Hinfray N., Porcher J.-M., Brion F. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2006, 144:252-262.
88. Hoeger B., Kollner B., Dietrich D.R., Hitzfeld B. Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat. Toxicol. 2005, 75:53-64.
89. Hong H.N., Kim H.N., Park K.S., Lee S.-K., Gu M.B. Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. Chemosphere 2007, 67:2115-2121.
90. Honkakoski P., Negishi M. Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem. J. 2000, 347:321-337.
91. Hu X., Li Y., Hu Z., Rudd J.A., Ling S., Jiang F., Davies H., Fang M. The alteration of 5-HT2A and 5-HT2C receptors is involved in neuronal apoptosis of goldfish cerebellum following traumatic experience. Neurochem. Int. 2012, 61:207-218.
92. Huang H., Wu Q. Cloning and comparative analyses of the zebrafish Ugt repertoire reveal its evolutionary diversity. PLoS ONE 2010, 5:0009144.
93. Ibabe A., Grabenbauer M., Baumgart E., Fahimi D.H., Cajaraville M.P. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochem. Cell Biol. 2002, 118:231-239.
94. Ibabe A., Grabenbauer M., Baumgart E., Völkl A., Fahimi H.D., Cajaraville M.P. Expression of peroxisome proliferator-activated receptors in the liver of gray mullet (Mugil cephalus). Acta Histochem. 2004, 106:11-19.
95. Ibabe A., Herrero A., Cajaraville M.P. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. Toxicol. In Vitro 2005, 19:725-735.
96. Isamah G.K., Asagba S.O. A comparative study on the archives of xanthine oxidase and aldehyde oxidase in different fish species from two rivers in the Western Niger-Delta. Environ. Monit. Assess. 2004, 91:293-300.
97. James M.O. Steroid catabolism in marine and freshwater fish. J. Steroid Biochem. Mol. Biol. 2011, 127:167-175.
98. Jarošová B., Bláha L., Giesy J.P., Hilscherová K. What level of estrogenic activity determined by in vitro assays in municipal waste waters can be considered as safe?. Environ. Int. 2014, 64:98-109.
99. Ji K., Choi K., Lee S., Park S., Khim J.S., Jo E.H., Zhang X., Giesy J.P. Effects of sulfathiazole, oxytetracycline and chlortetracycline on steroidogenesis in the human adrenocarcinoma (H295R) cell line and freshwater fish Oryzias latipes. J. Hazard Mater. 2010, 182:494-502.
100. Ji K., Liu X., Lee S., Kang S., Kho Y., Giesy J.P., Choi K. Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish. J. Hazard Mater. 2013, 254-255:242-251.
101. Jjemba P.J. Pharma-ecology: The Occurrence and Fate of Pharmaceuticals and Personal Care Products in the Environment 2008, 16-78. John Wiley & Sons, Inc., New Jersey.
102. Jobling S., Coey S., Whitmore J.G., Kime D.E., Van Look K.J.W., McAllister B.G., Beresford N., Henshaw A.C., Brighty G., Tyler C.R., Sumpter J.P. Wild intersex roach (Rutilus rutilus) have reduced fertility. Biol. Reprod. 2002, 67:515-524.
103. Jobling S., Nolan M., Tyler C.R., Brighty G., Sumpter J.P. Widespread sexual disruption in wild fish. Environ. Sci. Technol. 1998, 32:2498-2506.
104. Kahle M., Buerge I.J., Hauser A., Muller M.D., Poiger T. Azole fungicides: occurrence and fate in wastewater and surface waters. Environ. Sci. Technol. 2008, 42:7193-7200.
105. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Illicit drugs and pharmaceuticals in the environment - forensic applications of environmental data. Part 1: estimation of the usage of drugs in local communities. Environ. Pollut. 2009, 157:1773-1777.
106. Kidd K.A., Paterson M.J., Rennie M.D., Podemski C.L., Findlay D.L., Blanchfield P.J., Liber K. Direct and indirect responses of a freshwater food web to a potent synthetic oestrogen. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2014, 369.
107. Kirby M.F., Smith A.J., Rooke J., Neall P., Scott A.P., Katsiadaki I. Ethoxyresorufin-O-deethylase (EROD) and vitellogenin (VTG) in flounder (Platichthys flesus): system interaction, crosstalk and implications for monitoring. Aquat. Toxicol. 2007, 81:233-244.
108. Korashy H.M., Shayeganpour A., Brocks D.R., El-Kadi A.O. Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines. Toxicol. Sci. 2007, 97:32-43.
109. Kostich M.S., Batt A.L., Lazorchak J.M. Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ. Pollut. 2014, 184:354-359.
110. Kostich M.S., Lazorchak J.M. Risks to aquatic organisms posed by human pharmaceutical use. Sci. Total Environ. 2008, 389:329-339.
111. Kroupova H.K., Trubiroha A., Lorenz C., Contardo-Jara V., Lutz I., Grabic R., Kocour M., Kloas W. The progestin levonorgestrel disrupts gonadotropin expression and sex steroid levels in pubertal roach (Rutilus rutilus). Aquat. Toxicol. 2014, 154:154-162.
112. Kubota A., Bainy A.C.D., Woodin B.R., Goldstone J.V., Stegeman J.J. The cytochrome P450 2AA gene cluster in zebrafish (Danio rerio): expression of CYP2AA1 and CYP2AA2 and response to phenobarbital-type inducers. Toxicol. Appl. Pharmacol. 2013, 272:172-179.
113. Kubota A., Goldstone J.V., Lemaire B., Takata M., Woodin B.R., Stegeman J.J. Role of pregnane X receptor and aryl hydrocarbon receptor in transcriptional regulation of pxr, CYP2, and CYP3 genes in developing zebrafish. Toxicol. Sci. 2014.
114. Kümmerer K. Antibiotics in the aquatic environment - a review - Part I. Chemosphere 2009, 75:417-434.
115. Larsen H., Celander M., Goksøyr A. The cytochrome P450 system of Atlantic salmon (Salmo salar): II. Variations in hepatic catalytic activities and isozyme patterns during an annual reproductive cycle. Fish Physiol. Biochem. 1992, 10:291-301.
116. Laurenson J.P., Bloom R.A., Page S., Sadrieh N. Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data. AAPS J. 2014, 16:299-310.
117. Lavado R., Thibaut R., Raldúa D., Martín R., Porte C. First evidence of endocrine disruption in feral carp from the Ebro River. Toxicol. Appl. Pharmacol. 2004, 196:247-257.
118. Laville N., Ait-Aissa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196:41-55.
119. Lee H.-B., Peart T.E., Lewina Svoboda M., Backus S. Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. Chemosphere 2009, 77:1285-1291.
120. Lister A., Regan C., Van Zwol J., Van Der Kraak G. Inhibition of egg production in zebrafish by fluoxetine and municipal effluents: a mechanistic evaluation. Aquat. Toxicol. 2009, 95:320-329.
121. Liu J., Lu G., Ding J., Zhang Z., Wang Y. Tissue distribution, bioconcentration, metabolism, and effects of erythromycin in crucian carp (Carassius auratus). Sci. Total Environ. 2014, 490:914-920.
122. Liu J., Lu G., Wang Y., Yan Z., Yang X., Ding J., Jiang Z. Bioconcentration, metabolism, and biomarker responses in freshwater fish Carassius auratus exposed to roxithromycin. Chemosphere 2014, 99:102-108.
123. Liu J., Lu G., Wu D., Yan Z. A multi-biomarker assessment of single and combined effects of norfloxacin and sulfamethoxazole on male goldfish (Carassius auratus). Ecotoxicol. Environ. Saf. 2014, 102:12-17.
124. Loos R., Carvalho R., António D.C., Comero S., Locoro G., Tavazzi S., Paracchini B., Ghiani M., Lettieri T., Blaha L., Jarosova B., Voorspoels S., Servaes K., Haglund P., Fick J., Lindberg R.H., Schwesig D., Gawlik B.M. EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water Res. 2013, 47:6475-6487.
125. Lu M., Chang Z., Bae M.-J., Oh S.M., Chung K.-H., Park J.-S. Molecular characterization of the aryl hydrocarbon receptor (AhR) pathway in goldfish (Carassius auratus) exposure to TCDD: the mRNA and protein levels. Fish Shellfish Immunol. 2013, 35:469-475.
126. Lyssimachou A., Thibaut R., Gisbert E., Porte C. Gemfibrozil modulates cytochrome P450 and peroxisome proliferation-inducible enzymes in the liver of the yellow European eel (Anguilla anguilla). Environ. Sci. Pollut. Res. 2014, 21:862-871.
127. Manickum T., John W. Occurrence, fate and environmental risk assessment of endocrine disrupting compounds at the wastewater treatment works in Pietermaritzburg (South Africa). Sci. Total Environ. 2014, 468-469:584-597.
128. Mathas M., Burk O., Qiu H., Nusshag C., Godtel-Armbrust U., Baranyai D., Deng S., Romer K., Nem D., Windshugel B., Wojnowski L. Evolutionary history and functional characterization of the amphibian xenosensor CAR. Mol. Endocrinol. 2012, 26:14-26.
129. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ. Sci. Technol. 2010, 44:2176-2182.
130. Memmert U., Peither A., Burri R., Weber K., Schmidt T., Sumpter J.P., Hartmann A. Diclofenac: new data on chronic toxicity and bioconcentration in fish. Environ. Toxicol. Chem. 2013, 32:442-452.
131. Mennigen J.A., Lado W.E., Zamora J.M., Duarte-Guterman P., Langlois V.S., Metcalfe C.D., Chang J.P., Moon T.W., Trudeau V.L. Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat. Toxicol. 2010, 100:354-364.
132. Mennigen J.A., Martyniuk C.J., Crump K., Xiong H., Zhao E., Popesku J., Anisman H., Cossins A.R., Xia X., Trudeau V.L. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol. Genomics 2008, 35:273-282.
133. Merle R., Hajek P., Käsbohrer A., Hegger-Gravenhorst C., Mollenhauer Y., Robanus M., Ungemach F.-R., Kreienbrock L. Monitoring of antibiotic consumption in livestock: a German feasibility study. Prev. Vet. Med. 2012, 104:34-43.
134. Mimeault C., Woodhouse A.J., Miao X.S., Metcalfe C.D., Moon T.W., Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat. Toxicol. 2005, 73:44-54.
135. Miranda C.L., Henderson M.C., Buhler D.R. Evaluation of chemicals as inhibitors of trout cytochrome P450s. Toxicol. Appl. Pharmacol. 1998, 148:237-244.
136. Monod G., De Mones A., Fostier A. Inhibition of ovarian microsomal aromatase and follicular oestradiol secretion by imidazole fungicides in rainbow trout. Mar. Environ. Res. 1993, 35:153-157.
137. Monostory K., Pascussi J.-M., Kóbori L., Dvorak Z. Hormonal regulation of CYP1A expression. Drug Metab. Rev. 2009, 41:547-572.
138. Moore L.B., Maglich J.M., McKee D.D., Wisely B., Willson T.M., Kliewer S.A., Lambert M.H., Moore J.T. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 2002, 16:977-986.
139. Mortensen A.S., Arukwe A. Effects of 17alpha-ethynylestradiol on hormonal responses and xenobiotic biotransformation system of Atlantic salmon (Salmo salar). Aquat. Toxicol. 2007, 85:113-123.
140. Nassef M., Matsumoto S., Seki M., Khalil F., Kang I.J., Shimasaki Y., Oshima Y., Honjo T. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 2010, 80:1095-1100.
141. Navas J.M., Chana A., Herradon B., Segner H. Induction of cytochrome P4501A (CYPIA) by clotrimazole, a non-planar aromatic compound. Computational studies on structural features of clotrimazole and related imidazole derivatives. Life Sci. 2004, 76:699-714.
142. Navas J.M., Segner H. Estrogen-mediated suppression of cytochrome P4501A (CYP1A) expression in rainbow trout hepatocytes: role of estrogen receptor. Chem. Biol. Interact. 2001, 138:285-298.
143. Navas J.M., Zanuy S., Segner H., Carrillo M. Beta-naphthoflavone alters normal plasma levels of vitellogenin, 17 beta-estradiol and luteinizing hormone in sea bass broodstock. Aquat. Toxicol. 2004, 67:337-345.
144. Nelson D. A second CYP26 P450 in humans and zebrafish: CYP26B1. Arch. Biochem. Biophys. 1999, 371:345-347.
145. Notch E.G., Mayer G.D. Efficacy of pharmacological estrogen receptor antagonists in blocking activation of zebrafish estrogen receptors. Gen. Comp. Endocrinol. 2011, 173:183-189.
146. Ohare D.B., Siddall R., Robotham P.W.J., Gill R.A. Influence of estradiol on induction of EROD activity in roach (Rutilus rutilus L.). Chemosphere 1995, 30:1423-1428.
147. Ortiz-Delgado J.B., Sarasquete C., Behrens A., González de Canales M.L., Segner H. Expression, cellular distribution and induction of cytochrome P4501A (CYP1A) in gilthead seabream, Sparus aurata, brain. Aquat. Toxicol. 2002, 60:269-283.
148. Ortiz de García S., Pinto Pinto G., García Encina P., Irusta Mata R. Consumption and occurrence of pharmaceutical and personal care products in the aquatic environment in Spain. Sci. Total Environ. 2013, 444:451-465.
149. Parrott J.L., Blunt B.R. Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1ng/L reduces egg fertilization success and demasculinizes males. Environ. Toxicol. 2005, 20:131-141.
150. Peng X., Huang Q., Zhang K., Yu Y., Wang Z., Wang C. Distribution, behavior and fate of azole antifungals during mechanical, biological, and chemical treatments in sewage treatment plants in China. Sci. Total Environ. 2012, 426:311-317.
151. Peters L.D., Livingstone D.R., Shenin-Johnson S., Hines R.N., Schlenk D. Characterization of hepatic flavin monooxygenase from the marine teleost turbot (Scophthalmus maximus L.). Xenobiotica 1995, 25:121-131.
152. Petkam R., Renaud R.L., Leatherland J.F. The role of CYP 1A1 in the in vitro metabolism of pregnenolone by the liver of rainbow trout embryos. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 135:277-284.
153. Pinto C., Grimaldi M., Boulahtouf A., Pakdel F., Brion F., Aït-Aïssa S., Cavaillès V., Bourguet W., Gustafsson J.-A., Bondesson M., Balaguer P. Selectivity of natural, synthetic and environmental estrogens for zebrafish estrogen receptors. Toxicol. Appl. Pharmacol. 2014, 280:60-69.
154. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 2002, 141:41-61.
155. Prindiville J.S., Mennigen J.A., Zamora J.M., Moon T.W., Weber J.-M. The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout. Toxicol. Appl. Pharmacol. 2011, 251:201-208.
156. Ribalta C., Sole M. In vitro interaction of emerging contaminants with the cytochrome P450 system of Mediterranean deep-sea fish. Environ. Sci. Technol. 2014, 48:12327-12335.
157. Roberts P.H., Thomas K.V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2006, 356:143-153.
158. Rocha Monteiro P.R., Reis-Henriques M.A., Coimbra J. Polycyclic aromatic hydrocarbons inhibit in vitro ovarian steroidogenesis in the flounder (Platichthys flesus L.). Aquat. Toxicol. 2000, 48:549-559.
159. Ronis M.J., Celander M., Badger T.M. Cytochrome P450 enzymes in the kidney of the bobwhite quail (Colinus virginianus): induction and inhibition by ergosterol biosynthesis inhibiting fungicides. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1998, 121:221-229.
160. Roos V., Gunnarsson L., Fick J., Larsson D.G.J., Rudén C. Prioritising pharmaceuticals for environmental risk assessment: towards adequate and feasible first-tier selection. Sci. Total Environ. 2012, 421-422:102-110.
161. Roy N.K., Courtenay S.C., Chambers R.C., Wirgin I.I. Characterization of the aryl hydrocarbon receptor repressor and a comparison of its expression in Atlantic tomcod from resistant and sensitive populations. Environ. Toxicol. Chem. 2006, 25:560-571.
162. Ruyter B., Andersen Ø., Dehli A., Östlund Farrants A.-K., Gjøen T., Thomassen M.S. Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. Biochim. Biophys. Acta 1997, 1348:331-338.
163. Saaristo M., Craft J.A., Lehtonen K.K., Lindström K. An endocrine disrupting chemical changes courtship and parental care in the sand goby. Aquat. Toxicol. 2010, 97:285-292.
164. Sarasquete C., Segner H. Cytochrome P4501A (CYP1A) in teleostean fishes. A review of immunohistochemical studies. Sci. Total Environ. 2000, 247:313-332.
165. Saravanan M., Ramesh M. Short and long-term effects of clofibric acid and diclofenac on certain biochemical and ionoregulatory responses in an Indian major carp, Cirrhinus mrigala. Chemosphere 2013, 93:388-396.
166. Schlenk D. Use of aquatic organisms as models to determine the in vivo contribution of flavin-containing monooxygenases in xenobiotic biotransformation. Mol. Mar. Biol. Biotechnol. 1995, 4:323-330.
167. Schlenk D. Occurrence of flavin-containing monooxygenases in non-mammalian eukaryotic organisms. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1998, 121:185-195.
168. Schlenk D., Buhler D.R. Flavin-containing monooxygenase activity in liver microsomes from the rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 1991, 20:13-23.
169. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part 1: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
170. Shilling A.D., Carlson D.B., Williams D.E. Rainbow trout, Oncorhynchus mykiss, as a model for aromatase inhibition. J. Steroid Biochem. Mol. Biol. 1999, 70:89-95.
171. Shved N., Berishvili G., Baroiller J.-F., Segner H., Reinecke M. Environmentally relevant concentrations of 17α-ethinylestradiol (EE2) interfere with the growth hormone (GH)/insulin-like growth factor (IGF)-I system in developing bony fish. Toxicol. Sci. 2008, 106:93-102.
172. Silva L.J.G., Meisel L.M., Lino C.M., Pena A. Profiling serotonin reuptake inhibitors (SSRIs) in the environment: trends in analytical methodologies. Crit. Rev. Anal. Chem. 2014, 44:41-67.
173. Skolness S.Y., Durhan E.J., Jensen K.M., Kahl M.D., Makynen E.A., Villeneuve D.L., Ankley G.T. Effects of gemfibrozil on lipid metabolism, steroidogenesis, and reproduction in the fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2012, 31:2615-2624.
174. Slana M., Dolenc M.S. Environmental risk assessment of antimicrobials applied in veterinary medicine-a field study and laboratory approach. Environ. Toxicol. Pharmacol. 2013, 35:131-141.
175. Smith E.M., Chu S.G., Paterson G., Metcalfe C.D., Wilson J.Y. Cross-species comparison of fluoxetine metabolism with fish liver microsomes. Chemosphere 2010, 79:26-32.
176. Smith E.M., Iftikar F.I., Higgins S., Irshad A., Jandoc R., Lee M., Wilson J.Y. In vitro inhibition of cytochrome P450-mediated reactions by gemfibrozil, erythromycin, ciprofloxacin and fluoxetine in fish liver microsomes. Aquat. Toxicol. 2012, 109:259-266.
177. Smith E.M., Wilson J.Y. Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16 alpha-carbonitrile, rifampicin, and beta-naphthoflavone. Aquat. Toxicol. 2010, 97:324-333.
178. Soares J., Coimbra A.M., Reis-Henriques M.A., Monteiro N.M., Vieira M.N., Oliveira J.M.A., Guedes-Dias P., Fontaínhas-Fernandes A., Parra S.S., Carvalho A.P., Castro L.F.C., Santos M.M. Disruption of zebrafish (Danio rerio) embryonic development after full life-cycle parental exposure to low levels of ethinylestradiol. Aquat. Toxicol. 2009, 95:330-338.
179. Solé M., Porte C., Barceló D. Vitellogenin induction and other biochemical responses in carp, Cyprinus carpio, after experimental injection with 17α-ethynylestradiol. Environ. Contam. Toxicol. 2000, 38:494-500.
180. Solé M., Raldua D., Piferrer F., Barceló D., Porte C. Feminization of wild carp, Cyprinus carpio, in a polluted environment: plasma steroid hormones, gonadal morphology and xenobiotic metabolizing system. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2003, 136:145-156.
181. Sonoda J., Xie W., Rosenfeld J.M., Barwick J.L., Guzelian P.S., Evans R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13801-13806.
182. Stegeman J.J., Hahn M.E. Biochemistry and Molecular Biology of Monooxygenases: Current Perspectives on Forms, Functions, and Regulation of Cytochrome P450 in Aquatic Species 1994, Lewis Publishers, Boca Raton.
183. Stumpf M., Ternes T.A., Wilken R.-D., Silvana Vianna R., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 1999, 225:135-141.
184. Sumpter J.P., Donnachie R.L., Johnson A.C. The apparently very variable potency of the anti-depressant fluoxetine. Aquat. Toxicol. 2014, 151:57-60.
185. Sumpter J.P., Jobling S. Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ. Health Perspect. 1995, 7:173-178.
186. Thibaut R., Porte C. Effects of fibrates, anti-inflammatory drugs and antidepressants in the fish hepatoma cell line PLHC-1: cytotoxicity and interactions with cytochrome P450 1A. Toxicol. In Vitro 2008, 22:1128-1135.
187. Thibaut R., Schnell S., Porte C. The interference of pharmaceuticals with endogenous and xenobiotic metabolizing enzymes in carp liver: an in-vitro study. Environ. Sci. Technol. 2006, 40:5154-5160.
188. Triebskorn R., Casper H., Heyd A., Eikemper R., Kohler H.R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68:151-166.
189. Uno T., Ishizuka M., Itakura T. Cytochrome P450 (CYP) in fish. Environ. Toxicol. Pharmacol. 2012, 34:1-13.
190. Vaccaro E., Giorgi M., Longo V., Mengozzi G., Gervasi P.G. Inhibition of cytochrome P450 enzymes by enrofloxacin in the sea bass (Dicentrarchus labrax). Aquat. Toxicol. 2003, 62:27-33.
191. Villeneuve D.L., Knoebl I., Kahl M.D., Jensen K.M., Hammermeister D.E., Greene K.J., Blake L.S., Ankley G.T. Relationship between brain and ovary aromatase activity and isoform-specific aromatase mRNA expression in the fathead minnow (Pimephales promelas). Aquat. Toxicol. 2006, 76:353-368.
192. Vodicnik M.J., Lech J.J. The effect of sex steroids and pregnenolone-16-alpha-carbonitrile on the hepatic-microsomal monooxygenase system of rainbow-trout (Salmo-gairdneri). J. Steroid Biochem. Mol. Biol. 1983, 18:323-328.
193. Vosges M., Kah O., Hinfray N., Chadili E., Le Page Y., Combarnous Y., Porcher J.-M., Brion F. 17α-Ethinylestradiol and nonylphenol affect the development of forebrain GnRH neurons through an estrogen receptors-dependent pathway. Reprod. Toxicol. 2012, 33:198-204.
194. Wassmur B., Gräns J., Kling P., Celander M.C. Interactions of pharmaceuticals and other xenobiotics on hepatic pregnane X receptor and cytochrome P450 3A signaling pathway in rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2010, 100:91-100.
195. Wassmur B., Grans J., Norstrom E., Wallin M., Celander M.C. Interactions of pharmaceuticals and other xenobiotics on key detoxification mechanisms and cytoskeleton in Poeciliopsis lucida hepatocellular carcinoma, PLHC-1 cell line. Toxicol. In Vitro 2013, 27:111-120.
196. Watkinson A.J., Murby E.J., Kolpin D.W., Costanzo S.D. The occurrence of antibiotics in an urban watershed: from wastewater to drinking water. Sci. Total Environ. 2009, 407:2711-2723.
197. Weston A., Caminada D., Galicia H., Fent K. Effects of lipid-lowering pharmaceuticals bezafibrate and clofibric acid on lipid metabolism in fathead minnow (Pimephales promelas). Environ. Toxicol. Chem. 2009, 28:2648-2655.
198. Westphal J.F. Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. Br. J. Clin. Pharmacol. 2000, 50:285-295.
199. Whyte J.J., Jung R.E., Schmitt C.J., Tillitt D.E. Ethoxyresorufin-O-deethylase (EROD) activity in fish as a biomarker of chemical exposure. Crit. Rev. Toxicol. 2000, 30:347-570.
200. Wong R.Y., Oxendine S.E., Godwin J. Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment. BMC Genomics 2013, 14.
201. Xu C., Li C.Y., Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28:249-268.
202. Yan Z., Lu G., Wu D., Ye Q., Xie Z. Interaction of 17β-estradiol and ketoconazole on endocrine function in goldfish (Carassius auratus). Aquat. Toxicol. 2013, 132-133:19-25.
203. Zhang W., Ramamoorthy Y., Kilicarslan T., Nolte H., Tyndale R.F., Sellers E.M. Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab. Dispos. 2002, 30:314-318.
204. Zhou H., Wu H., Liao C., Diao X., Zhen J., Chen L., Xue Q. Toxicology mechanism of the persistent organic pollutants (POPs) in fish through AhR pathway. Toxicol. Mech. Methods 2010, 20:279-286.
205. Zhou Y., Zha J., Wang Z. Occurrence and fate of steroid estrogens in the largest wastewater treatment plant in Beijing, China. Environ. Monit. Assess. 2012, 184:6799-6813.
206. Zlabek V., Zamaratskaia G. Comparison of three fluorescent CYP3A substrates in two vertebrate models: pig and Atlantic salmon. Animal 2012, 6:633-640.
207. Zucchi S., Castiglioni S., Fent K. Progestins and antiprogestins affect gene expression in early development in zebrafish (Danio rerio) at environmental concentrations. Environ. Sci. Technol. 2012, 46:5183-5192.